New England Journal of Medicine Retracts COVID-19 Study

Restricted access

The New England Journal of Medicine has retracted one of the articles cited in the June Kidney News article, “Evidence Mounts that RAS-Blocking Medications Pose No Danger to COVID-19.”

The Kidney News article described this retracted article as “a database study of 8910 [COVID-19] patients who had been hospitalized in 11 countries on three continents. That study found that neither ACE inhibitors nor ARBs were associated with an increased risk of in-hospital death.”

The retraction of this one article does not materially affect the KN article’s conclusion citing an expert consensus that